{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:29Z","timestamp":1786119149024,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"DOI":"10.1097\/qai.0b013e31815b0d48","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T10:00:19Z","timestamp":1236247219000},"page":"399-401","source":"Crossref","is-referenced-by-count":6,"title":["Similar Efficacy of Lopinavir\/Ritonavir-Containing Regimens Among Clades B and F HIV-1-Infected Individuals in Brazil"],"prefix":"10.1097","volume":"47","author":[{"given":"Ricardo Sobhie","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo L","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Tenore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Turcato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pal\u00e1cios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Sucupira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/135965350400900115","article-title":"Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.","volume":"9","author":"Witvrouw","year":"2004","journal-title":"Antivir Ther"},{"key":"R2-21-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00126334-200008010-00016","article-title":"Effects of CCR5 genetic polymorphism and HIV-1 subtype in antiretroviral response in Brazilian HIV-1-infected patients.","volume":"24","author":"Accetturi","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-21-20210131","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1086\/430002","article-title":"Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism.","volume":"191","author":"Calazans","year":"2005","journal-title":"J Infect Dis"},{"key":"R4-21-20210131","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/apc.2006.0079","article-title":"High levels of primary antiretroviral resistance genotypic mutations and B\/F recombinants in Santos, Brazil.","volume":"21","author":"Sucupira","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"R5-21-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/aid.2006.22.1","article-title":"Identification of two HIV type 1 circulating recombinant forms in Brazil.","volume":"22","author":"De Sa Filho","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R6-21-20210131","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.qai.0000180077.59159.f4","article-title":"Lopinavir\/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).","volume":"40","author":"Arribas","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-21-20210131","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/135965350601100510","article-title":"Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir.","volume":"11","author":"Ananworanich","year":"2006","journal-title":"Antivir Ther"},{"key":"R8-21-20210131","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(06)69155-1","article-title":"The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial.","volume":"368","author":"Eron","year":"2006","journal-title":"Lancet"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-200803010-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:37:00Z","timestamp":1786037820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200803010-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31815b0d48","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}